Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
MOE Key Laboratory of Bioinformatics, School of Life Sciences, Tsinghua University, Beijing 100084, China.
Molecules. 2023 Feb 9;28(4):1667. doi: 10.3390/molecules28041667.
Agarwood, a highly valuable resin/wood combination with diverse pharmacological activities but scarce supply, has a long history of being used as a medicine in several medical systems. Grafted Kynam agarwood (GKA) has been cultivated successfully recently and has the qualities meeting the definition of premium Kynam agarwood. However, there are few comprehensive comparisons between GKA and normal agarwood in terms of traits, global composition, and activity, and some key issues for GKA to be adopted into the traditional Chinese medical (TCM) system have not been elaborated. The two types of agarwood samples were evaluated in terms of trait characteristics, physicochemical indicators, key component groups, and global compositional profile. Furthermore, a molecular docking was performed to investigate the active ingredients. In vitro activity assays were performed to evaluate the activation of adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) by GKA and normal agarwood. The results revealed that, overall, the traits, microscopic characteristics, chemical composition types, and bioactivity between GKA and normal agarwood were similar. The main differences were the content of resin (ethanolic extract content), the content of key component groups, and the composition of the different parent structural groups of 2-(2-phenethyl) chromones (PECs). The contents of total PEC and ethanol extract content of GKA were significantly higher than those of normal agarwood. The MS-based high-throughput analysis revealed that GKA has higher concentrations of sesquiterpenes and flindersia-type 2-(2-phenylethyl) chromones (FTPECs) (m/z 250-312) than normal agarwood. Molecular docking revealed that parent structural groups of FTPECs activated multiple signaling pathways, including the AMPK pathway, suggesting that FTPECs are major active components in GKA. The aim of this paper is to describe the intrinsic reasons for GKA as a high-quality agarwood and a potential source for novel drug development. We combined high-throughput mass spectrometry and multivariate statistical analysis to infer the different components of the two types of agarwood. Then we combined virtual screening and in vitro activity to construct a component/pharmacodynamic relationship to explore the causes of the activity differences between agarwood with different levels of quality and to identify potentially valuable lead compounds. This strategy can also be used for the comprehensive study of other TCMs with different qualities.
沉香,一种具有多种药理活性的高价值树脂/木材组合,但供应稀缺,在几种医学体系中作为药物使用已有悠久的历史。最近成功培育了嫁接奇楠沉香(GKA),其品质符合优质奇楠沉香的定义。然而,关于 GKA 与普通沉香在性状、整体成分和活性方面的综合比较较少,并且一些关键问题尚未详细阐述 GKA 被纳入中医(TCM)体系。两种类型的沉香样本在性状特征、理化指标、关键成分组和整体组成谱方面进行了评估。此外,还进行了分子对接以研究活性成分。进行了体外活性测定以评估 GKA 和普通沉香对 5'-单磷酸腺苷(AMP)激活的蛋白激酶(AMPK)的激活作用。结果表明,总体而言,GKA 和普通沉香在性状、微观特征、化学成分类型和生物活性方面相似。主要区别在于树脂(醇提物含量)的含量、关键成分组的含量以及 2-(2-苯乙基)色酮(PECs)不同母体结构基团的组成。GKA 的总 PEC 和乙醇提取物含量明显高于普通沉香。基于 MS 的高通量分析表明,GKA 中含有较高浓度的倍半萜和弗林德斯型 2-(2-苯乙基)色酮(FTPECs)(m/z 250-312)。分子对接表明,FTPEC 的母体结构基团激活了多种信号通路,包括 AMPK 通路,这表明 FTPEC 是 GKA 的主要活性成分。本文的目的是描述 GKA 作为高质量沉香和新型药物开发的潜在来源的内在原因。我们结合高通量质谱和多元统计分析来推断两种沉香的不同成分。然后,我们结合虚拟筛选和体外活性构建成分/药效关系,以探索不同质量水平沉香活性差异的原因,并鉴定有潜在价值的先导化合物。这种策略也可用于其他具有不同质量的 TCM 的综合研究。